Carregant...
Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma
BACKGROUND: Clozapine remains the antipsychotic of choice for refractory schizophrenia. Given the particular side effects of clozapine including neutropenia and myelosuppression, safety and efficacy of add-on chemotherapy for patients who are already under clozapine treatment remain unknown. OBJECTI...
Guardat en:
| Publicat a: | Ther Adv Psychopharmacol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4257985/ https://ncbi.nlm.nih.gov/pubmed/25489479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125314553610 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|